The store will not work correctly when cookies are disabled.
(E)-3-oxo-1,3-dihydroisobenzofuran-5-yl-(4-bromo)cinnamate
ID: ALA4578745
PubChem CID: 155565108
Max Phase: Preclinical
Molecular Formula: C17H11BrO4
Molecular Weight: 359.18
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccc(Br)cc1)Oc1ccc2c(c1)C(=O)OC2
Standard InChI: InChI=1S/C17H11BrO4/c18-13-5-1-11(2-6-13)3-8-16(19)22-14-7-4-12-10-21-17(20)15(12)9-14/h1-9H,10H2/b8-3+
Standard InChI Key: MGTTUEXHSMQMOZ-FPYGCLRLSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
7.2377 -9.6247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2366 -10.4442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9446 -10.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9429 -9.2158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6515 -9.6211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6517 -10.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4304 -10.6924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9114 -10.0300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4300 -9.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6822 -8.5906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5299 -9.2162 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8223 -9.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1145 -9.2166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8225 -10.4422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4069 -9.6253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6991 -9.2169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7028 -8.3995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9958 -7.9911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2872 -8.3999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2900 -9.2214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9976 -9.6260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5789 -7.9924 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
1 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.18 | Molecular Weight (Monoisotopic): 357.9841 | AlogP: 3.74 | #Rotatable Bonds: 3 |
Polar Surface Area: 52.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.70 | CX Basic pKa: ┄ | CX LogP: 4.50 | CX LogD: 4.50 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.48 | Np Likeness Score: 0.25 |
References
1. Rodrigues MP, Tomaz DC, Ângelo de Souza L, Onofre TS, Aquiles de Menezes W, Almeida-Silva J, Suarez-Fontes AM, Rogéria de Almeida M, Manoel da Silva A, Bressan GC, Vannier-Santos MA, Rangel Fietto JL, Teixeira RR.. (2019) Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis., 183 [PMID:31542714] [10.1016/j.ejmech.2019.111688] |